The 20 Best Pancreatic Pseudocyst Doctors Near Me in Ann Arbor, MI

Dr. Kwon joined the Division of Gastroenterology in 2005 and is currently a Clinical Professor. He received his bachelor's degree from Amherst College and his medical degree from UCLA Medical School. He completed his internal medicine residency at Cedars-Sinai Medical Center and his gastroenterology fellowship at Brigham and Women's Hospital (BWH). He also completed his advanced endoscopy fellowship at the combined BWH and Massachusetts General Hospital program. He earned his Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr. Kwon is currently the Director of Advanced Endoscopy, Program Director for the Advanced Endoscopy fellowship, and Co-director of the Comprehensive Pancreas Program. He also serves as the Medical Director of the Michigan Chapter of the National Pancreas Foundation. He is a principal investigator in several independently funded research studies and has been an author on over 100 publications, including multiple research studies, national guidelines, and book chapters. He is a sought-after speaker, having served as invited faculty at multiple regional, national and international courses. Dr. Kwon is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Bile Duct Obstruction, Pancreatic Cancer, Endoscopy, and Lithotripsy. Dr. Kwon is board certified in Gastroenterology.

Erik-Jan Wamsteker, MD is a Clinical Associate Professor in the Division of Gastroenterology and Hepatology. Dr. Wamsteker earned his medical degree from UMDNJ Rutgers Medical school (New Jersey Medical School). He completed his internal medicine residency at the University of Michigan and Gastroenterology Fellowship where he focused his training in Advanced Endoscopy with a focus in ERCP and EUS. He is board certified in Gastroenterology.Dr. Wamsteker has authored numerous peer-reviewed articles, abstracts, and book chapters. He has served as a councilor of the AGA Institute Council Pancreatic Disorders Section as well as a counselor to the ACG practice parameters committee tasked with clinical guideline development and serves on the Board of the National Pancreas Foundations Michigan Chapter. He is an active faculty member in the training of GI fellows both for the general GI fellowship as well as Advanced Endoscopy Fellowship programs. He runs the monthly Advanced Endoscopy Conference as well as gives didactic lectures to Internal Medicine residents and GI fellows on various topics focused on endoscopic management of pancreatic and biliary disorders as well as endoscopic oncology.Personal Interests:Music history, listening to music especially on vinyl, print making, greyhounds. Dr. Wamsteker is rated as an Advanced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Neuroma Biliary Tract, Bile Duct Obstruction, Childhood Pancreatitis, Pancreatectomy, and Gastrectomy. Dr. Wamsteker is board certified in Gastroenterology.

George Philips is a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Philips is rated as an Advanced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Bile Duct Stricture, Cholestasis, Colonoscopy, and Endoscopy.

Allison Schulman, MD, MPH, FASGE, FACG is an Associate Professor and dually appointed in the Division of Gastroenterology and Hepatology and the Department of Surgery. She received her bachelor's degree from Cornell University in Ithaca, New York, and her medical degree from Weill Cornell Medical College in New York City, where she was inducted into the Alpha Omega Alpha (AOA) Medical Honor Society. She received a Master’s in Public Health (MPH) at Harvard University. She completed her residency in Internal Medicine at the Brigham and Women's Hospital in Boston, MA. Following residency training, Dr. Schulman completed fellowship in Gastroenterology, and went on to complete two additional fellowships in Bariatric Endoscopy followed by Advanced/Therapeutic Endoscopy. All of her training was at Harvard/Brigham and Women's Hospital. She joined faculty at Michigan in 2017 and was appointed Director of Bariatric Endoscopy and more recently selected as Chief of Endoscopy in 2023.Dr. Schulman's research has focused on endoscopic management of obesity and device development/innovation in therapeutic endoscopy. She is specifically interested in the management of complications following bariatric surgery, primary endoscopic therapy for obesity, and therapeutic endoscopic ultrasound (EUS). She also has interests in interventional hepatology and ERCP.She is a member of the Clinical Excellence Society and participates in committees through many gastroenterology and surgical societies, and is the current Chair of the Association of Bariatric Endoscopy (ABE/ASGE). Dr. Schulman is rated as an Advanced provider by MediFind in the treatment of Pancreatic Pseudocyst. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Gastrointestinal Fistula, Choledocholithiasis, Hereditary Pancreatitis, Gastric Bypass, and Endoscopy. Dr. Schulman is board certified in Gastroenterology.

Ammar Hassan is an Internal Medicine specialist and a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Hassan is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Enlarged Liver, Cirrhosis, Liver Transplant, and Endoscopy.

Jeremy Adler is a Pediatric Gastroenterologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Colonoscopy.

Adam Cardullo is a Pediatric Gastroenterologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Cardullo is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Chronic Idiopathic Constipation (CIC), Esophagitis, Celiac Disease, and Gastrostomy. Dr. Cardullo is board certified in Pediatric Gastroenterology and Pediatrics.

Victoria Shakhin is a Pediatrics specialist and a Pediatric Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Shakhin is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Biliary Atresia, Macroamylasemia, Gilbert Syndrome, Rotor Syndrome, and Liver Transplant. Dr. Shakhin is board certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bednar is board certified in Surgery and Complex General Surgical Oncology.

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Executive Vice Chair of the Department of Surgery, Surgical Director of Living Donor Liver Transplantation, and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. He is a Professor in the Department of Surgery, Section of Transplantation, and Professor of Health Management and Policy at the School of Public Health. Dr. Sonnenday received his medical degree from Vanderbilt University in 1997, and completed his General Surgery residency at the Johns Hopkins University in 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health. After completion of his residency, Dr. Sonnenday continued at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until 2006, and he completed a fellowship in abdominal transplant surgery at the University of Michigan in 2008. His primary academic and research interests include the study of frailty in liver transplant candidates, machine perfusion in liver transplantation, the overlap of transplant and oncology, quality collaboratives in transplantation, and leadership development in academic surgery.Clinical Specialization: Dr. Sonnenday's clinical interests focus on liver transplantation, hepatobiliary and pancreatic surgery, and general surgery procedures in patients with advanced liver disease. He sees patients in the Multidisciplinary Liver Tumor Clinic at the University of Michigan Rogel Cancer Center and the Transplant Clinic at the Taubman Center. Dr. Sonnenday is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy. Dr. Sonnenday is board certified in Surgery.

John Del Valle is an Internal Medicine specialist and a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Del Valle is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Colitis, and Colonoscopy. Dr. Del Valle is board certified in Internal Medicine and Gastroenterology.

Dr. Grewal is a graduate of Edward Via College of Osteopathic Medicine in Auburn, Alabama. She completed her residency at McLaren Greater Lansing in Lansing, Michigan, where she also served as Chief Resident. Her clinical interests include preventive care, complex chronic medical conditions and neurocognitive disorders. Dr. Grewal was raised in Tampa, Florida and completed her undergraduate studies at the University of South Florida. In her free time, she enjoys spending time with her family, traveling, reading and watching sports. Dr. Grewal is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. Her clinical expertise encompasses Strep Throat, Sepsis, Childhood Pancreatitis, and Pulmonary Embolism.

Beth Manoogian is an Internal Medicine specialist and a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Manoogian is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Cholangitis, and Colonoscopy.

Dr. Ferguson is a Clinical Assistant Professor of Surgery in the Division of Hepato-pancreato-biliary Surgery. Following undergraduate studies in Molecular & Integrative Physiology at the University of Illinois, he earned an MD and a PhD in Cancer Biology at the University of Chicago. He completed a general surgery residency at the University of Chicago, where he served as an administrative chief resident and completed a medical education fellowship, followed by a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in general surgery and complex general surgical oncology.He has won numerous teaching awards at every stage of his career. He is the co-editor of Difficult Decisions in Surgical Oncology—An Evidence-Based Approach. He is active in the American College of Surgeons, Society of Surgical Oncology, Americas Hepato-Pancreato-Biliary Association, and Association for Surgical Education.Clinical Specialization: Dr. Ferguson's clinical expertise is in the management of cancers and premalignant conditions of the pancreas, liver, bile ducts, gallbladder, and stomach. Dr. Ferguson is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Ferguson is board certified in Surgery and Complex General Surgical Oncology.

Ryan Stidham is a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Stidham is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

Evan Glazer, MD, PhD, FACS, is the Clinical Director of the Pancreatic Cancer Program at Michigan Medicine and the Associate Director of Clinical Research in the Rogel and Blondy Center for Pancreatic Cancer. Dr. Glazer earned his medical degree and a master's degree in public health at the George Washington University in Washington, DC. Subsequently, he completed residency in general surgery and completed a PhD in Cancer Biology at the University of Arizona, in Tucson, AZ. Dr. Glazer completed an NIH funded T32 training fellowship at the M.D. Anderson Cancer Center in Houston, TX. He completed a fellowship in complex general surgical oncology at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr. Glazer is board certified in complex general surgical oncology and general surgery. His clinical and research focuses are on pancreatic and liver malignancies.After completing fellowship in Tampa, Dr. Glazer joined the University of Tennessee Health Science Center in Memphis, TN, and rose in rank to Associate Professor. He served as program director of the complex general surgical oncology fellowship there as well as associate program director for research in the general surgery residency program. Dr. Glazer is a member of the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology, Association of Academic Surgery, and American Society of Clinical Oncology. With a national reputation, he has served on the Hepatobiliary Panel and Pancreatic Adenocarcinoma Panel for the National Comprehensive Cancer Network. He has served numerous roles for the Society of Surgical Oncology. Dr. Glazer is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Glazer is board certified in Surgery and Complex General Surgical Oncology.

Mohamed Salim is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Salim is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. His clinical expertise encompasses Sepsis, Lymphangitis, Peptic Ulcer, Endoscopy, and Gastrostomy. Dr. Salim is board certified in Internal Medicine.

John Y. Kao, MD,Professor of Medicine,Associate Vice Chair of Basic & Translational Research, Department of Internal MedicineCo-Director of NIH T32 Training Program in Basic and Translational Digestive Sciences,Division of Gastroenterology & HepatologyMichigan MedicineUniversity of Michigan Medical School.Dr. Kao completed his undergraduate degree at the University of California in Los Angeles, his MD degree at the University of Southern California, his Internal Medicine residency at UC Davis, and his combined Basic Research and Clinical Gastroenterology Fellowship at the University of Michigan. For the past 20 years, his research has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has resulted in >100 papers. He is an elected member of the American Society of Clinical Investigation (ASCI) and currently serves as a permanent member of the NIH Digestive System Host Defense, Microbial Interactions, and Immune and Inflammatory Diseases (DHMI) study sections. Dr. Kao’s research program focused on understanding the role of gut microbes in chronic inflammatory disorders with an emphasis on the homeostatic mechanisms of host–microbe interaction in the gastrointestinal tract. Current studies in this laboratory use genetically engineered and experimental mouse models to investigate several epithelial and immune pathways critical for maintaining mucosal homeostasis. Current projects funded by DoD/VA and NIH include probing the pathways involved in the development of Helicobacter-associated intestinal metaplasia and the role of epithelial NADPH oxidases, Duox2, in preventing gut bacterial translocation. Understanding these pathways may lead to new therapeutic strategies and targets for the prevention of bacterial-driven gut inflammation and its associated malignant complications. His clinical work is centered on the care of complicated refractory H. pylori infection. He also co-founded the Fecal Microbiota Transplant program for the treatment of refractory C. difficile infection. Dr. Kao is also passionate about mentoring and serves as the co-director of the NIH T32 Basic and Translational Digestive Science Research Training Program. In his spare time, he enjoys playing tennis with colleagues at Michigan Medicine and traveling with his wife, Sherry, who is Section Lead of Optometry at Kellogg Eye Center, and with their three children and miniature poodle, Boba. Dr. Kao is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Helicobacter Pylori Infection, Viral Gastroenteritis, Celiac Disease, Colonoscopy, and Endoscopy. Dr. Kao is board certified in Gastroenterology.

Shanti Eswaran is an Internal Medicine specialist and a Gastroenterologist practicing medicine in Ann Arbor, Michigan. Dr. Eswaran is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Irritable Bowel Syndrome (IBS), Diarrhea, Chronic Idiopathic Constipation (CIC), Endoscopy, and Colonoscopy. Dr. Eswaran is board certified in Gastroenterology.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.